Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FEUL
Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ
FEUL
|
+$302M |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$273M |
| 3 |
Petrobras
PBR
|
+$272M |
| 4 |
BHP
BHP
|
+$266M |
| 5 |
Freeport-McMoran
FCX
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$460M |
| 2 |
FIEU
FI Enhanced Europe 50 ETN
FIEU
|
+$267M |
| 3 |
FLEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series B
FLEU
|
+$239M |
| 4 |
HDFC Bank
HDB
|
+$227M |
| 5 |
Comcast
CMCSA
|
+$227M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.36% |
| 2 | Technology | 15.02% |
| 3 | Healthcare | 11.86% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Consumer Staples | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $21M | 0.03% |
251,972
+14,599
| +6% | +$1.22M |
|
252
ICICI Bank
IBN
$108B
| $20.9M | 0.03% |
2,604,746
-9,051,831
| -78% | -$77.6M |
|
253
NNN REIT
NNN
$9.04B
| $20.9M | 0.03% |
475,300
-47,456
| -9% | -$1.91M |
|
|
SRCI
254
DELISTED
SRC Energy Inc
SRCI
| $20.7M | 0.03% |
1,875,474
+1,559,623
| +494% | +$17.4M |
|
255
CVS Health
CVS
$133B
| $20.4M | 0.03% |
317,675
+17,250
| +6% | +$1.14M |
|
256
Veeco
VECO
$3.05B
| $20.2M | 0.03% |
1,418,825
-4,956
| -0.3% | -$82K |
|
257
ATI
ATI
$25.6B
| $20.1M | 0.03% |
+801,153
| New | +$21.7M |
|
258
Live Nation Entertainment
LYV
$40.5B
| $19.9M | 0.03% |
408,801
-9,264
| -2% | -$397K |
|
|
NTUS
259
DELISTED
Natus Medical Inc
NTUS
| $19.8M | 0.03% |
574,375
-560
| -0.1% | -$19.6K |
|
260
Medtronic
MDT
$109B
| $19.4M | 0.03% |
226,743
+9,787
| +5% | +$817K |
|
|
GHL
261
DELISTED
Greenhill & Co., Inc.
GHL
| $18.6M | 0.02% |
655,817
-10,282
| -2% | -$251K |
|
262
Haemonetics
HAE
$3.89B
| $18.5M | 0.02% |
205,764
-13,347
| -6% | -$1.13M |
|
263
Wipro
WIT
$19.6B
| $18.4M | 0.02% |
10,238,704
-1,540,552
| -13% | -$2.8M |
|
264
Union Pacific
UNP
$174B
| $18.4M | 0.02% |
129,572
-45,565
| -26% | -$6.35M |
|
265
Toll Brothers
TOL
$13.6B
| $18.3M | 0.02% |
493,839
-8,912
| -2% | -$365K |
|
266
Semtech
SMTC
$11B
| $18M | 0.02% |
383,052
-33,762
| -8% | -$1.51M |
|
267
ICU Medical
ICUI
$4.21B
| $17.9M | 0.02% |
61,000
| – | – |
|
268
Paycom
PAYC
$7.64B
| $17.8M | 0.02% |
180,419
-29,039
| -14% | -$3.13M |
|
269
Emergent Biosolutions
EBS
$373M
| $17.8M | 0.02% |
351,575
-26,288
| -7% | -$1.37M |
|
270
Honeywell
HON
$77B
| $17.6M | 0.02% |
134,972
-5,500
| -4% | -$732K |
|
271
COPT Defense Properties
CDP
$4.3B
| $17.6M | 0.02% |
605,582
-3,418
| -0.6% | -$93.7K |
|
272
IPG Photonics
IPGP
$3.61B
| $17.4M | 0.02% |
79,015
-6,020
| -7% | -$1.42M |
|
273
Fidelity National Information Services
FIS
$23.1B
| $16.9M | 0.02% |
159,830
-10,357
| -6% | -$1.05M |
|
274
LivaNova
LIVN
$4.4B
| $16.3M | 0.02% |
163,000
| – | – |
|
275
Fair Isaac
FICO
$24.3B
| $16.1M | 0.02% |
83,196
-4,661
| -5% | -$844K |
|
Similar funds
Ken Fisher's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Fisher held 924 positions worth $77B, up 2.1% from $75.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q2 2018 filing shows 95 new, 298 increased, 389 reduced and 62 closed positions. Its largest new stake was Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ: 3,218,864 shares worth $294M. The largest sale was Amazon, an estimated $460M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q2 2018 buy was Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ: 3,218,864 shares worth $294M.
- Ken Fisher added most to Barclays ETN+ FI Enhanced Europe 50 ETN Series C in Q2 2018, an estimated $273M increase.
- Ken Fisher's biggest Q2 2018 reduction was Amazon, cutting an estimated $460M.
- Ken Fisher fully exited Dr. Reddy's Laboratories in Q2 2018, selling an estimated $165M.
- Ken Fisher's ten largest holdings make up 26% of its $77B portfolio in Q2 2018.
- Ken Fisher opened 95 new positions and closed 62 in Q2 2018.
- Ken Fisher's portfolio value rose 2.1% quarter-over-quarter to $77B.
Based on Fisher Asset Management's 13F filing for Q2 2018, filed 9 Jul 2018.